tykhr
sign in
free sign up
Kindred Biosciences Inc
Drug Manufacturers-Specialty & Generic
Healthcare
KIN
45.44M shares
NASDAQ US
traded
27 Aug 2021
open
9.24
52 week high
9.25
high
9.26
52 week low
3.49
low
9.24
growth
86.09%
previous Close
9.24
P/E ratio
-46
market cap
419M
div yield
0
usd
Jun 2021
qoq
revenue
3.54M
47.68 %
net incoming
-9.13M
6.28 %
eps
-0.20
16.67 %
eps surprise
-8.52 %
net profit margin
-258.07 %
148.00 %
operating incoming
-8.54M
6.79 %
net change in cash
33.80M
2,518.44 %
cash on hand
46.72M
261.82 %
cost of revenue
639K
8.31 %
top